Krystal Biotech (KRYS)
301.00
-6.79 (2.21%)
Upcoming Events
Latest Headlines
Form 4 Krystal Biotech, Inc. For: Jun 04 Filed by: Krishnan Suma
June 5, 2026 6:41 PM - SEC Filing
Form 4 Krystal Biotech, Inc. For: Jun 04 Filed by: Krishnan Krish S
June 5, 2026 6:39 PM - SEC Filing
Form 144 Krystal Biotech, Inc. Filed by: Krishnan Suma
June 4, 2026 4:31 PM - SEC Filing
Form 144 Krystal Biotech, Inc. Filed by: Krishnan Krish S
June 4, 2026 4:31 PM - SEC Filing
Form 4 Krystal Biotech, Inc. For: May 26 Filed by: Thomas John Charles
May 27, 2026 5:18 PM - SEC Filing
Form 144 Krystal Biotech, Inc. Filed by: Thomas John Charles
May 26, 2026 10:31 AM - SEC Filing
Corbus names Nishant Saxena as chief business officer
May 21, 2026 8:01 AM - StreetInsider
Form 8-K Krystal Biotech, Inc. For: May 15
May 20, 2026 6:02 AM - SEC Filing
Krystal Biotech gains UK approval for VYJUVEK gene therapy
May 18, 2026 8:02 AM - StreetInsider
Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
May 18, 2026 8:01 AM - Globe NewsWire
Krystal Biotech to Present at BofA Securities 2026 Health Care Conference
May 7, 2026 8:00 AM - Globe NewsWire
Krystal Biotech (KRYS) PT Raised to $399 at Jefferies
May 4, 2026 2:04 PM - StreetInsider
Krystal Biotech (KRYS) PT Lowered to $323 at BofA Securities
May 4, 2026 10:40 AM - StreetInsider
Form SCHEDULE 13G/A Krystal Biotech, Inc. Filed by: Krishnan Krish S
May 4, 2026 7:11 AM - SEC Filing
Form 8-K Krystal Biotech, Inc. For: May 04
May 4, 2026 7:07 AM - SEC Filing
Form 10-Q Krystal Biotech, Inc. For: Mar 31
May 4, 2026 7:06 AM - SEC Filing
Krystal Biotech, Inc. (KRYS) Tops Q1 EPS by 35c
May 4, 2026 7:03 AM - StreetInsider
Krystal Biotech Announces First Quarter 2026 Financial and Operating Results
May 4, 2026 7:00 AM - Globe NewsWire
Krystal Biotech to Present at Upcoming Scientific Conferences
April 30, 2026 8:00 AM - Globe NewsWire
Form SCHEDULE 13G Krystal Biotech, Inc. Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC
April 29, 2026 2:16 PM - SEC Filing
Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026
April 21, 2026 8:01 AM - Globe NewsWire
Form ARS Krystal Biotech, Inc. For: Dec 31
April 3, 2026 4:35 PM - SEC Filing
Form DEFA14A Krystal Biotech, Inc.
April 3, 2026 4:33 PM - SEC Filing
Form DEF 14A Krystal Biotech, Inc. For: Apr 03
April 3, 2026 4:31 PM - SEC Filing
Form SCHEDULE 13G/A Krystal Biotech, Inc. Filed by: VANGUARD GROUP INC
March 27, 2026 10:19 AM - SEC Filing
Wolfe Research Starts Krystal Biotech (KRYS) at Peerperform
March 26, 2026 4:08 PM - StreetInsider
Palvella Therapeutics hires Jennifer McDonough as senior VP
March 24, 2026 9:50 AM - StreetInsider
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
March 24, 2026 9:50 AM - Globe NewsWire
Palvella hires Jennifer McDonough as market access VP
March 23, 2026 7:30 AM - StreetInsider
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
March 23, 2026 7:30 AM - Globe NewsWire
Full Article List
